-
2 weeks ago | 
pulmonaryhypertensionnews.com | Margarida Maia |Jen Cueva
Pulmonary artery denervation (PADN), a procedure that targets overactive nerves involved in blood vessel constriction, significantly lessens high blood pressure in the lungs of people with pulmonary hypertension (PH), according to a meta-analysis of more than a dozen studies. Pooled data also showed that the approach was associated with significant improvements in heart function and exercise capacity, further supporting its “promise as a therapeutic intervention for PH,” the researchers wrote.
-
1 month ago | 
pulmonaryhypertensionnews.com | Patricia Inacio |Jen Cueva
I’m the almost-pour-milk-onto-my-mom’s-plate-instead-of-in-her-cup kind of tired. The dump-potato-chips-instead-of-cat-food-into-my-cat’s-bowl kind of distracted. The place-things-on-my-parents’-stairlift-instead-of-carrying-them-up-or-down-the-steps kind of exhausted. My name is Colleen Steele, and I have caregiver burnout!It’s not the first time I’ve burned the candle at both ends. I cared for my son Cullen, 25, many times through this level of physical and emotional fatigue.
-
1 month ago | 
pulmonaryhypertensionnews.com | Andrea Lobo |Jen Cueva |Marisa Wexler |Steve Bryson
Tenax Therapeutics said it will extend its Phase 3 clinical development of an oral form of levosimendan for pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF). The company last year received $100 million in funding to help it complete an ongoing Phase 3 LEVEL trial (NCT05983250) testing TNX-103. Tenax said it will now extend recruitment to at least 230 participants, increasing the trial’s statistical power.
-
Jan 13, 2025 | 
pulmonaryhypertensionnews.com | Steve Bryson |Jen Cueva |Mike Naple
It’s a beautiful day in the country for what appears to be the beginning of autumn. There are acres of trees, mostly green except for a few that have changed to gold. They’re casting a shadow over a lake, but on the other side sun is glistening on the water and the land is covered in lush, green grass. It appears to be a wide-open field except for the ruins of an old fence. All that remains is a small gate held up by two standing pillars.
-
Jan 8, 2025 | 
pulmonaryhypertensionnews.com | Jen Cueva
Are you managing chronic pain alongside pulmonary hypertension (PH)? Did it disrupt your holiday plans? If you answered yes, you’re not alone. Many folks in the PH and broader rare disease communities share similar frustrations with having to adjust plans because of unrelenting pain. Dealing with chronic pain is an invisible battle that affects not only the body but also the mind. Pain shows up uninvited, especially during moments I look forward to, such as when I’m spending time with loved ones.
-
Dec 4, 2024 | 
pulmonaryhypertensionnews.com | Jen Cueva |Steve Bryson
If I asked you to list every medication you or a loved one takes — along with the doses — could you do it? You might be surprised how many in the pulmonary hypertension (PH) community can’t recall those details when it matters most. This year, I learned just how crucial it is to keep an updated medication list on hand during a hospital stay — a lesson that may have saved me some serious trouble. Here’s what happened.
-
Nov 28, 2024 | 
pulmonaryhypertensionnews.com | Anna Jeter |Mike Naple |Jen Cueva
When I was in college and my health was in decline with pulmonary hypertension, I had a month when my symptoms became exacerbated. That led to a week of things becoming noticeably worse, which led to a day of increasing worry. By 9 at night, I felt I had to tell my mom, mainly because I was afraid of what might happen if I went to sleep. My symptoms had been building for a while, and they’d hit the point where I genuinely felt scared for my well-being.
-
Nov 27, 2024 | 
pulmonaryhypertensionnews.com | Steve Bryson |Jen Cueva |Marisa Wexler
Winrevair (sotatercept-csrk) significantly reduced the risk of all-cause death, a lung transplant, or hospitalization among adults with pulmonary arterial hypertension (PAH) at a high risk of dying enrolled in a Phase 3 clinical trial. These top-line findings in the ongoing ZENITH trial (NCT04896008), testing the Merck treatment against a placebo while on background therapy, led an independent data monitoring committee to recommend the trial be stopped early.
-
Nov 25, 2024 | 
pulmonaryhypertensionnews.com | Jen Cueva |Anna Jeter |Helen Baldwin
Music is a universal gift given and received by people of all ages, ethnicities, and cultures. Its versatile melodies, rhythms, harmonies, lyrics, and instruments adapt to any person, place, situation, mood, and event. Music is the keeper of memories, the creator of dreams, and the healer of mind, body, and soul. It cultivates love and consoles broken hearts. It’s a prayer, a push to be brave, a reason to smile, a shoulder to cry on, and a pillow for rest.
-
Nov 20, 2024 | 
pulmonaryhypertensionnews.com | Esteban Cerezo |Jen Cueva |Margarida Maia |Patricia Inacio
Platelets, or cell fragments in blood that help stop or prevent bleeding, tend to cluster in lung blood vessels of people with decompensated pulmonary hypertension (PH), a lung disease characterized by sudden worsening of clinical signs of right heart failure, followed by other severe complications, a study has found. This clustering, or aggregation, is associated with low platelet counts in these patients, increasing their risk of bleeding.
